Triptorelin (2mg)

Triptorelin Peptide

Triptorelin is a synthetic Peptide composed of ten amino acids, similar to gonadotropin-releasing hormones (GnRH).⁽¹⁾ GnRH, secreted by the hypothalamus, is considered by scientists to be responsible for the synthesis and secretion of the follicle-stimulating hormone (FSH) and luteinizing hormone (LH).⁽²⁾ Triptorelin may act similarly on the pituitary gland to stimulate the synthesis and release of the LH and FSH hormones, both apparently vital for testosterone production in male species and estrogen synthesis in female species.⁽³⁾

Overview

As an agonist analog of GnRH, researchers have suggested that Triptorelin binds to the receptors in the pituitary gland, which may then stimulate the secretion of LH and FSH. This, at first, may cause an upsurge in the initial phase of LH and FSH stimulation. However, it is important to note that Triptorelin is an analog that appears to have upregulated stability and affinity to the receptors than endogenous GnRH. Thus, the receptors eventually may become less sensitive to the compound (i.e., downregulation of the receptors), and Triptorelin may lead to reduced release of LH and FSH.

Scientists consider that a reduction in the levels of LH and FSH hormones eventually leads to a decrease in testosterone and estrogen levels. This event may lead to the suppression of steroidogenesis by ovaries and testicles.⁽⁴⁾ Researchers suggest that Triptorelin exhibits some potential in sustaining the decline in LH and FSH secretion. Therefore, intermittent exposure to Triptorelin may upregulate hormonal levels, while prolonged exposure may lead to dramatic suppression.

Chemical Makeup

Molecular Formula: C₆₄H₈₂N₁₈O₁₃
Molecular Weight: 1311.4 g/mol
Other Known Titles: 57773-63-4

Research and Clinical Studies

Triptorelin Peptide and Hormonal Upregulation

It is posited that a single exposure to Triptorelin may, under certain experimental conditions, potentially induce a surge in hormone release from cells by interacting with receptors that control gonadotropin secretion.⁽⁵⁾ This single interaction may temporarily reset or stimulate the hypothalamic-pituitary axis, thereby possibly enhancing the secretion of endogenous gonadotropins and subsequent hormonal synthesis. It is hypothesized that Triptorelin might activate signaling pathways that had been previously suppressed or downregulated, possibly leading to an increase in luteinizing hormone release and ultimately fostering the synthesis of androgens. The signaling pathways may be suppressed due to previous exposure to androgenic anabolic agents, which may

“have pronounced effects on the male pituitary-gonadal axis, affecting the regulation of production of serum luteinizing hormone (LH) and follicle-stimulating hormone and inducing a state of hypogonadotropic hypogonadism characterized by decreased serum endogenous testosterone production and impaired spermatogenesis”.

Studies employing controlled conditions have suggested that even a one-time exposure could serve as a catalyst for restoring or augmenting endogenous hormone production. The underlying biological processes, however, remain complex and may depend on multiple variables that have yet to be fully elucidated.

Triptorelin Peptide and Hormonal Suppression

Prolonged exposure to triptorelin may, according to various mechanistic hypotheses, alter the normal function of GnRH receptors.⁽⁶⁾ Instead of the typical pulsatile pattern that is possibly required to maintain receptor sensitivity, the continuous presence of a GnRH analog might potentially lead to a state of receptor desensitization. This desensitization, as posited by some researchers, may potentially be tied to alterations in receptor trafficking, where receptors may become internalized and apparently not recycled to the cell surface as efficiently. Such a process may diminish their ability to respond to further stimulation, thereby reducing the secretion of upstream hormones, and ultimately lowering the synthesis of downstream hormones.

Studies employing controlled research approaches have hinted that this continuous stimulation may induce conformational changes in the receptor or associated signaling proteins. These changes may disrupt the receptor’s normal feedback and resensitization mechanisms. Over time, this condition could result in persistently dampened signaling cascades, potentially leading to less hormonal release and reduced hormone production at later stages in the endocrine pathway.

Triptorelin Peptide and Thymus Cells

In murine models, GnRH-analog peptides structurally related to Triptorelin have been posited to interact with specific binding sites within thymic compartments, potentially influencing immune-related processes.⁽⁷⁾ It is possible that age-related reductions in LHRH-binding sites, coupled with complex endocrine-immune signaling pathways, obscure the precise manner in which Triptorelin might modulate thymic function. The researchers have commented that the peptide may “exert a powerful modulation of immune system function during the physiological decline of immunological capacities.” However, the limited data currently available may stem from the difficulty in separating local thymic actions from broader neuroendocrine influences, as well as from the challenges of elucidating how these peptides apparently alter receptor densities, cellular organization, and the proliferative capacity of T-lymphocyte precursors. Therefore, it remains uncertain how Triptorelin could potentially modulate immunity at the molecular and cellular level.

Triptorelin peptide is available for research and laboratory purposes only. Please review and adhere to our Terms and Conditions before ordering.

References:

1. National Center for Biotechnology Information. PubChem Compound Summary for CID 25074470, Triptorelin.
2. Tsutsumi, Rie, and Nicholas J G Webster. “GnRH pulsatility, the pituitary response and reproductive dysfunction.” Endocrine journal vol. 56,6 (2009): 729-37. doi:10.1507/endocrj.k09e-185. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307809/
3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Triptorelin. https://www.ncbi.nlm.nih.gov/books/NBK548756/
4. Lepor, Herbert. “Comparison of single-agent androgen suppression for advanced prostate cancer.” Reviews in urology vol. 7 Suppl 5 (2005): S3-S12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477619/
5. Pirola I, Cappelli C, Delbarba A, Scalvini T, Agosti B, Assanelli D, Bonetti A, Castellano M. Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism. Fertil Steril. 2010 Nov;94(6):2331.e1-3. doi: 10.1016/j.fertnstert.2010.03.042. Epub 2010 Apr 22. PMID: 20416868.
6. Chung LY, Kang E, Nam HK, Rhie YJ, Lee KH. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center. J Korean Med Sci. 2021 Aug 30;36(34):e219. doi: 10.3346/jkms.2021.36.e219. PMID: 34463062; PMCID: PMC8405405.
7. Marchetti B, Guarcello V, Morale MC, Bartoloni G, Raiti F, Palumbo G Jr, Farinella Z, Cordaro S, Scapagnini U. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology. 1989 Aug;125(2):1037-45. doi: 10.1210/endo-125-2-1037. PMID: 2546733.